News & Insights

Gunderson Dettmer represented Akouos Inc in its $50 million Series A financing round led by NEA with participation from 5AM and Partners Innovation.

Gunderson Dettmer served as lead counsel to WindMIL Therapeutics in its $32.5 million Series B financing round led by Qiming Venture Partners USA with participation from Medivate Partners, Camden Partners Nexus, Domain Associates and FOXKISER.

Gunderson Dettmer served as lead counsel to Synchronoss Technologies in its partial acquisition by Siris Capital.

Forbes recognized 16 Gunderson Dettmer company and venture capital firm clients in its 13th annual 30 Under 30 North America list. 

Hospital IQ, a leading provider of intelligent automation solutions for hospitals, is acquired by LeanTaaS, a developer of analytical software for hospitals.

Andreessen Horowitz (a16z) leads the $50 million Series A financing of PROOF, an operator of media, podcasts, and events about non-fungible tokens (NFTs).

Non-profit organization that supports entrepreneurs with bold, disruptive ideas from non-traditional backgrounds, MassChallenge, announces strategic partnership with Gunderson Dettmer to expand its reach into building partnerships in both traditional and non-traditional institutions. 

Gunderson Dettmer has elected 11 new partners, effective January 1, 2023. These elevations add to the firm’s Corporate and Securities, Executive Compensation, Fund Formation, and Licensing, Strategic Partnering and Commercial Transactions practices.